Systematic Reviews
Copyright ©The Author(s) 2018.
World J Crit Care Med. Feb 4, 2018; 7(1): 24-30
Published online Feb 4, 2018. doi: 10.5492/wjccm.v7.i1.24
Table 1 Characteristics of the sample
Sample characteristics (n = 120)Results
Age (yr)
Mean ± SD58.5 ± 19.4
Minimum-maximum15-91
Gender n (%)
Male69 (57.5)
Female51 (42.5)
APACHE II (score)
Mean ± SD27.4 ± 6.7
Minimum–maximum8-47
Risk of mortality (%)-APACHE II
Mean ± SD61.8 ± 7.3
Admission diagnoses n (%)
Diseases of the circulatory system43 (35.8)
Diseases of the respiratory system15 (12.5)
Lesions, poisoning and other consequences of external causes14 (11.7)
Gastrointestinal diseases8 (6.7)
Unclassified signs and symptoms8 (6.7)
Diseases of the genitourinary system7 (5.8)
Neoplasia4 (3.3)
Nervous system disorders4 (3.3)
Infectious and parasitic diseases3 (2.5)
Endocrine, nutritional and metabolic diseases3 (2.5)
Other11 (9.2)
Mechanical ventilators n (%)
1Servo S89 (74.2)
1Servo 900203 (16.7)
1Dixtal11 (9.2)
Table 2 Respiratory mechanics and oxygenation index on the 1st and 5th day
Oxygenation index
Mean ± SDMinimum-maximum
Respiratory mechanics
1st day (n = 120)
PaO2/FiO2 (mmHg)236.0 ± 97.647.0-465.7
Compliance-VCV (mL/cm H2O)40.9 ± 12.815.0-88.0
Resistance-VCV (cm H2O/L/s)13.2 ± 4.94.1-28.6
Compliance-PCV (mL/cm H2O)35.0 ± 10.015.0-62.0
Resistance-PCV (cm H2O/L/s)27.3 ± 16.29.1-131.1
5th day (n = 77)
PaO2/FiO2 (mmHg)241.7 ± 88.758.0-445.0
Compliance-VCV (mL/cm H2O)39.7 ± 13.218.0-83.0
Resistance-VCV (cm H2O/L/s)13.8 ± 6.05.3-43.0
Compliance-PCV (mL/cm H2O)32.9 ± 9.313.5-52.5
Resistance-PCV (cm H2O/L/s)26.4 ± 11.86.2-73.5
Table 3 Numeric variables and ventilator-associated pneumonia
VariablesVAP
P value
YesNo
APACHE II129.2 ± 5.626.5 ± 7.10.026
Age (yr)57.1 ± 19.159.2 ± 19.60.565
1st day (n = 120)
PaO2/FiO2 (mmHg)1232.3 ± 79.9237.8 ± 105.20.756
Compliance-VCV (mL/cmH2O)43.1 ± 14.939.8 ± 11.60.365
Resistance-VCV (cmH2O/L/s)13.7 ± 5.013.0 ± 4.80.594
Compliance-PCV (mL/cmH2O)134.8 ± 10.435.1 ± 9.80.879
Resistance-PCV (cmH2O/L/s)23.6 ± 10.329.0 ± 18.10.114
5th day (n = 77)
PaO2/FiO2 (mmHg)1244.1 ± 94.1240.2 ± 86.10.850
Compliance-VCV (mL/cmH2O)43.3 ± 14.037.6 ± 12.30.092
Resistance-VCV (cmH2O/L/s)13.9 ± 6.813.8 ± 5.50.996
Compliance-PCV (mL/cmH2O)133.6 ± 8.932.5 ± 9.60.606
Resistance-PCV (cmH2O/L/s)27.1 ± 11.725.9 ± 12.00.777
(n = 120)
Duration of MV (d)18.4 ± 14.910.7 ± 6.80.001
Length of stay in ICU (d)20.4 ± 15.312.8 ± 7.60.003
Table 4 Numeric variables and death
VariablesOutcome
P value
HighDeath
APACHE II127.0 ± 7.627.7 ± 5.80.606
Age (yr)51.1 ± 19.965.4 ± 16.1< 0.001
1st day (n = 120)
PaO2/FiO2 (mmHg)1263.1 ± 100.9210.7 ± 87.80.003
Compliance-VCV (mL/cm H2O)43.5 ± 12.538.4 ± 12.60.015
Resistance-VCV (cm H2O/L/s)13.3 ± 4.313.2 ± 5.40.935
Compliance-PCV (mL/cm H2O)136.6 ± 9.833.6 ± 9.90.103
Resistance-PCV (cm H2O/L/s)25.0 ± 10.529.4 ± 20.00.416
5th day (n = 77)
PaO2/FiO2 (mmHg)1268.8 ± 81.9214.7 ± 87.90.004
Compliance-VCV (mL/cm H2O)40.7 ± 12.738.7 ± 13.70.356
Resistance-VCV (cm H2O/L/s)14.2 ± 5.013.5 ± 6.90.22
Compliance-PCV (mL/cm H2O)134.1 ± 9.431.8 ± 9.10.282
Resistance-PCV (cm H2O/L/s)25.7 ± 10.827.1 ± 12.90.76
(n = 120)
Duration of MV (d)14.5 ± 12.411.9 ± 8.60.212
Length of stay in ICU (d)18.3 ± 12.512.4 ± 8.9< 0.001
Table 5 Relative risk for ventilator-associated pneumonia and outcomes
VariablesRR95%CIP value
VAP
APACHE II above the average1.621.03-2.550.016
Male gender1.561.18-2.080.004
Resistance worsening-PCV1.851.16-2.940.01
Outcome: Death
Age above the average2.081.34-3.230.001
Compliance-VCV below average on 1st day1.491.00-2.210.032
ICU stay below the average2.051.28-3.280.001